Biomarker discovery from uveal melanoma secretomes: Identification of gp100 and cathepsin D in patient serum

Journal of Proteome Research

Volumn 6, Issue 7, 2007, Pages 2802-2811

  Pardo, María ^a,c   García, Ángel ^a,c   Antrobus, Robin ^a   Blanco, María José ^b   Dwek, Raymond A ^a   Zitzmann, Nicole ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b HOSPITAL DE CONXO   (Spain)

^c UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Biomarker; Cathepsin D; gp100; Proteomics; Secretome; Syntenin; Uveal melanoma

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER; CATHEPSIN D; GLYCOPROTEIN GP 100; SYNTENIN; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEOMICS; UVEA MELANOMA;

ANTIBODIES, NEOPLASM; AUTOANTIBODIES; CATHEPSIN D; CELL LINE, TUMOR; HUMANS; MELANOMA; MEMBRANE GLYCOPROTEINS; PROTEOME; TUMOR MARKERS, BIOLOGICAL; UVEAL NEOPLASMS;

EID: 34547217974     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr070021t     Document Type: Article

References (69)

1. Singh, A. D.; Topham, A. Survival rates with uveal melanoma in the United States: 1973-1997. Ophthalmology 2003, 110, 962-965.
2. Eskelin, S.; Pyrhonen, S.; Summanen, P.; Hahka-Kemppinen, M.; Kivela, T. Tumor doubling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatment. Ophthalmology 2000, 107, 1443-1449.
3. Singh, A. D.; Shields, C. L.; Shields, J. A. Prognostic factors in uveal melanoma. Melanoma Res. 2001, 11, 255-263.
4. Sholes, A. G.; Damato, B. E.; Nunn, J.; Hiscott, P. Grierson, I.; Field, J. K. Monosomy 3 in uveal melanoma: correlation with clinical and histologic predictors of survival. Invest. Ophthalmol. Vis. Sci. 2003, 44, 1008-1011.
5. Mouriaux, F.; Maurage, C. A.; Labalette, P.; Sablonniere, B.; Malecaze, F.; Darbon, J. M. Cyclin-dependent kinase inhibitory protein expression in human choroidal melanoma tumors. Invest. Ophthalmol. Vis. Sci. 2000, 41, 2837-2843.
6. Pardo, M.; Piñeiro, A.; de la Fuente, M.; García, A.; Prabhakar, S.; Zitzmann, N.; Dwek, R. A.; Sánchez-Salorio, M.; Domínguez, F.; Capeans, C. Abnormal cell cycle regulation in primary human uveal melanoma cultures. J. Cell. Biochem. 2004, 93, 708-720.
7. Anastassiou, G.; Schilling, H.; Stang, A.; Djakovic, S.; Heiligenhaus, A.; Bornfeld, N. Expression of the cell adhesion molecules ICAM-1, V-CAM-1 and NCAM in uveal melanoma: a clinicopathological study. Oncology 2000, 58, 83-88.
8. Loercher, A. E.; Harbour, J. W. Molecular genetics of uveal melanoma. Curr. Eye Res. 2003, 27, 69-74.
9. Celis, J. E.; Gromov, P.; Cabezon, T.; Moreira, J. M.; Ambartsumian, N.; Sandelin, K.; Rank, F.; Gromova, I. Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery. Mol. Cell. Proteomics 2004, 3, 327-344.
10. Knezevic, V.; Leethanakul, C.; Bichsel, V. E.; Worth, J. M.; Prabhu, V. V.; Gutkind, J. S.; Liotta, L. A.; Munson, P. J.; Petricoin, E. F 3rd. Proteomic profiling of the cancer microenvironment by antibody arrays. Proteomics 2001, 1, 1271-1278.
11. Old, L. J.; Chen, Y. T. New paths in human cancer serology. J. Exp. Med. 1998, 187, 1163-1167.
12. Le, Naour, F.; Misek, D. E.; Krause, M. C.; Deneux, L.; Giordano, T. J.; Scholl, S.; Hanash, S. M. Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer. Clin. Cancer Res. 2001, 7, 3328-3335.
13. Tan, E. M. Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis. J. Clin. Invest. 2001, 108, 1411-1415.
14. Cheever, M. A.; Disis, M. L.; Bernhard, H.; Gralow, J. R.; Hand, S. L.; Huseby, E. S.; Qin, H. L.; Takahashi, M.; Chen, W. Immunity to oncogenic proteins. Immunol. Rev. 1995, 145, 33-59.
15. Pardo, M.; García, A.; Thomas, B.; Piñeiro, A.; Akoulitchev, A.; Dwek, R. A.; Zitzmann, N. Proteome analysis of a human uveal melanoma primary cell culture by 2-DE and MS. Proteomics 2005, 5, 4980-4993.
16. Pardo, M.; García, A.; Thomas, B.; Piñeiro, A.; Akoulitchev, A.; Dwek, R. A.; Zitzmann, N. The characterization of the invasion phenotype of uveal melanoma tumour cells shows the presence of MUC18 and HMG-1 metastasis markers and leads to the identification of DJ-1 as a potential serum biomarker. Int. J. Cancer 2006, 119, 1014-1022.
17. Diebold, Y.; Blanco, G.; Saornil, M. A.; Fernandez, N.; Lazaro, M. C. Morphologic and immunocytochemical characterization of four human uveal cell lines (melanoma- and melanocytes-derived). Curr. Eye Res. 1997, 16, 487-495.
18. Hassner, A.; Birnbaum, D.; Loew, L. M. Charge-shift probes of membrane potential biosynthesis. J. Org. Chem. 1984, 49, 2546-2551.
19. Sanchez, J. C.; Rouge, V.; Pisteur, M.; Ravier, F.; Tonella, L.; Moosmayer, M.; Wilkins, M. R.; Hochstrasser, D. F. Improved and simplified in-gel sample application using rewelling of dry immobilized pH gradients. Electrophoresis 1997, 18, 324-7.
20. Shevchenko, A.; Jensen, O. N.; Podtelejnikov, A. V.; Sagliocco, F.; Wilm, M.; Vorm, O.; Mortensen, P.; Shevchenko, A.; Boucherie, H.; Mann, M. Linking genome and proteome by mass spectrometry: large-scale identification of yeast proteins from two dimensional gels. Proc. Natl. Acad. Sci. U.SA. 1996, 93, 14440-1445.
21. Wu, C. C.; Chien, K. Y.; Tsang, N. M.; Chang, K. P.; Hao, S. P.; Tsao, C. H.; Chang, Y. S.; Yu, J. S. Cancer cell-secreted proteomes as a basis for searching potential tumor markers: nasopharyngeal carcinoma as a model. Proteomics 2005, 5, 3173-3182.
22. Gronborg, M.; Kristiansen, T. Z.; Iwahori, A.; Chang, R.; Reddy, R.; Sato, N.; Molina, H.; Jensen, O. N.; Hruban, R. H.; Goggins, M. G.; et al. Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach. Mol. Cell. Proteomics 2006, 5, 157-171.
23. Mbeunkui, F.; Fodstad, O.; Pannell, L. K. Secretory protein enrichment and analysis: an optimized approach applied on cancer cell lines using 2D LC-MS/MS. J. Proteome Res. 2006, 5, 899-906.
24. Hendrix, M. J.; Seftor, E. A.; Seftor, R. E.; Kirschmann, D. A.; Gardner, L. M.; Boldt, H. C.; Meyer, M.; Pe'er, J.; Folberg, R. Regulation of uveal melanoma interconverted phenotype by hepatocyte growth factor/scatter factor (HGF/SF). Am. J. Pathol. 1998, 152, 855-863.
25. Economou, M. A.; All-Ericsson, C.; Bykov, V.; Girnita, L.; Bartolazzi, A.; Larsson, O.; Seregard, S. Receptors for the liver synthesized growth factors IGF-1 and HGF/SF in uveal melanoma: intercorrelation and prognostic implications. Invest. Ophthalmol. Vis. Sci. 2005, 46, 4372-4375.
26. Mooy, C. M.; Luyten, G. P.; de Jong, P. T.; Jensen, O. A.; Luider, T. M.; van der Ham, F.; Bosman, F. T. Neural cell adhesion molecule distribution in primary and metastatic uveal melanoma. Hum. Pathol. 1995, 26, 1185-1190.
27. Anastassiou, G.; Schilling, H.; Stang, A.; Djakovic, S.; Heiligenhaus, A.; Bornfeld, N. Expression of the cell adhesion molecules ICAM-1, VCAM-1 and NCAM in uveal melanoma: a clinicopathological study. Oncology 2000, 58, 83-88.
28. Koo, T. H.; Lee, J. J.; Kim, E. M.; Kim, K. W.; Kim, H. D.; Lee, J. H. Syntenin is overexpressed and promotes cell migration in metastatic human breast and gastric cancer cell lines. Oncogene 2002, 21, 4080-4088.
29. Helmke, B. M.; Polychronidis, M.; Benner, A.; Thome, M.; Arribas, J.; Deichmann, M. Melanoma metastasis is associated with enhanced expression of the syntenin gene. Oncol. Rep. 2004, 12, 221-228.
30. Kawakami, Y.; Eliyahu, S.; Delgado, C. H.; Robbins, P. F.; Rivoltini, L.; Topalian, S. L.; Miki, T.; Rosenberg, S. A. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. Natl. Acad. Sci. U.SA. 1994, 91, 3515-3519.
31. Bartenjev, I.; Rudolf, Z.; Stabuc, B.; Vrhovec, I.; Perkovic, T.; Kansky, A. Cathepsin D expression in early cutaneous malignant melanoma. Int. J. Dermatol. 2000, 39, 599-602.
32. Lou, X.; Xiao, T.; Zhao, K.; Wang, H.; Zheng, H.; Lin, D.; Lu, Y.; Gao, Y.; Cheng, S.; Liu, S.; et al. Cathepsin D is secreted from M-BE cells: its potential role as a biomarker of lung cancer. J. Proteome Res. 2007, 6, 1083-1092.
33. Mauri, P.; Scarpa, A.; Nascimbeni, A. C.; Benazzi, L.; Parmagnani, E.; Mafficini, A.; Delia, Peruta, M.; Bassi, C.; Miyazaki, K.; Sorio, C. Identification of proteins released by pancreatic cancer cells by multidimensional protein identification technology: a strategy for identification of novel cancer markers. FASEB J. 2005, 19, 1125-1127.
34. Xiao, T.; Ying, W.; Li, L.; Hu, Z.; Ma, Y.; Jiao, L.; Ma, J.; Cai, Y.; Lin, D.; Guo, S.; et al. An approach to studying lung cancer-related proteins in human blood. Mol. Cell. Proteomics 2005, 4, 1480-1486.
35. Mbeunkui, F.; Fodstad, O.; Pannell, L. K. Secretory protein enrichment and analysis: an optimized approach applied on cancer cell lines using 2D LC-MS/MS. J. Proteome Res. 2006, 5, 899-906.
36. Denzer, K.; Kleijmeer, M. J.; Heijnen.; H. F.; Stoorvogel, W.; Geuz, H. J. Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. J. Cell Sci. 2000, 19, 3365-3374.
37. Thery, C.; Zitvogel, L.; Amigorena, S. Exosomes: composition, biogenesis and function. Nat. Rev. Immunol. 2002, 2, 569-579.
38. van Niel, G.; Porto-Carreiro, I.; Simoes, S.; Raposo, G. Exosomes: a common pathway for a specialized function. J. Biochem. (Tokyo) 2006, 140, 13-21.
39. Fevrier, B.; Raposo, G. Exosomes: endosomal-derived vesicles shipping extracellular messages. Curr. Opin. Cell Biol. 2004, 16, 415-421.
40. Whiteside, T. L. Tumour-derived exosomes or microvesicles: another mechanism of tumour escape from the host immune system? Br. J. Cancer 2005, 92, 209-211.
41. Koga, K.; Matsumoto, K.; Akiyoshi, T.; Kubo, M.; Yamanaka, N.; Tasaki, A.; Nakashima, H.; Nakamura, M.; Kuroki, S.; Tanaka, M.; et al. Purification, characterization and biological significance of tumor-derived exosomes. Anticancer Res. 2005, 25, 3703-3707.
42. Taylor, D. D.; Gercel-Taylor, C. Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects. Br. J. Cancer 2005, 92, 305-311.
43. Shaw, M. M.; Riederer, B. M. Sample preparation for two-dimensional gel electrophoresis. Proteomics 2003, 3, 1408-1417.
44. Neufeld, G.; Shraga-Heled, N.; Lange, T.; Guttmann-Raviv, N.; Herzog, Y.; Kessler, O. Semaphorins in cancer. Front. Biosci. 2005, 10, 751-760.
45. Kantor, D. B.; Chivatakarn, O.; Peer, K. L.; Oster, S. F.; Inatani, M.; Hansen, M. J.; Flanagan, J. G.; Yamaguchi, Y.; Sretavan, D. W.; Giger, R. J.; et al. Semaphorin 5A is a bifunctional axon guidance cue regulated by heparan and chondroitin sulfate proteoglycans. Neuron 2004, 44, 961-975.
46. Artigiani, S.; Conrotto, P.; Fazzari, P.; Gilestro, G. F.; Barberis, D.; Giordano, S.; Comoglio, P. M.; Tamagnone, L. Plexin-B3 is a functional receptor for semaphorin 5A. EMBO Rep. 2004, 5, 710-714.
47. Mechtersheimer, S.; Gutwein, P.; Agmon-Levin, N.; Stoeck, A.; Oleszewski, M.; Riedle, S.; Postina, R.; Fahrenholz, F.; Fogel, M.; Lemmon, V.; et al. Ectodomain shedding of L1 adhesion molecule promotes cell migration by autocrine binding to integrins. J. Cell Biol. 2001, 155, 661-673.
48. Fogel, M.; Gutwein, P.; Mechtersheimer, S.; Riedle, S.; Stoeck, A.; Smirnov, A.; Edler, L.; Ben-Arie, A.; Huszar, M.; Altevogt, P. L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomas. Lancet 2003, 362, 869-875.
49. Heiz, M.; Grunberg, J.; Schubiger, P. A.; Novak-Hofer, I. Hepatocyte growth factor-induced ectodomain shedding of cell adhesion molecule L1: role of the L1 cytoplasmic domain. J. Biol. Chem. 2004, 279, 31149-31156.
50. Repp, A. C.; Mayhew, E. S.; Apte, S.; Niederkorn, J. Y. Human uveal melanoma cells produce macrophage migration-inhibitory factor to prevent lysis by NK cells. J. Immunol. 2000, 165, 710-715.
51. Soussi, T. p53 Antibodies in the sera of patients with various types of cancer: a review. Cancer Res. 2000, 60, 1777-1788.
52. Hutchinson, J. N.; Jin, J.; Cardiff, R. D.; Woodgett, J. R.; Muller, W. J. Activation of Akt-1 (PKB-alpha) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion. Cancer Res. 2004, 64, 3171-3178.
53. Konstandoulakis, M. M.; Syrigos, K. N.; Leandros, M.; Charalabopoulos, A.; Manouras, A.; Golematis, B. C. Autoantibodies in the serum of patients with gastric cancer: their prognostic importance. Hybridoma 1998, 17, 431-435.
54. Nakanishi, T.; Takeuchi, T.; A, Ueda, K.; Murao, H.; Shimizu, A. Detection of eight antibodies in cancer patients' sera against proteins derived from the adenocarcinoma A549 cell line using proteomics-based analysis. J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 2006, 838, 15-20.
55. Ueda, K. Proteome analysis of autoantibodies in sera of patients with cancer. Rinsho Byori 2005, 53, 437-445.
56. Fernandez-Madrid, F.; Tang, N.; Alansari, H.; Granda, J. L.; Tait, L.; Amirikia, K. C.; Moroianu, M.; Wang, X.; Karvonen, R. L. Autoantibodies to Annexin XI-A and Other Autoantigens in the Diagnosis of Breast Cancer. Cancer Res. 2004, 64, 5089-5096.
57. Jalbout, M.; Bel Hadj Jrad, B.; Bouaouina, N.; Gargouri, J.; Yacoub, S.; Zakhama, A.; Khlifa, R.; Chouchane, L. Autoantibodies to tubulin are specifically associated with the young age onset of the nasopharyngeal carcinoma. Int. I. Cancer 2002, 101, 146-150.
58. Brichory, F. M.; Misek, D. E.; Yim, A. M.; Krause, M. C.; Giordano, T. J.; Beer, D. G.; Hanash, S. M. An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer. Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 9824-9829.
59. Maciel, C. M.; Junqueira, M.; Paschoal, M. E.; Kawamura, M. T.; Duarte, R. L.; Carvalho Mda, G.; Domont, G. B. Differential proteomic serum pattern of low molecular weight proteins expressed by adenocarcinoma lung cancer patients. J. Exp. Ther. Oncol. 2005, 5, 31-38.
60. Huang, H. L.; Stasyk, T.; Morandell, S.; Dieplinger, H.; Falkensammer, G.; Griesmacher, A.; Mogg, M.; Shreiber, M.; Feuerstein, I.; Huck, C. W.; et al. Biomarker discovery in breast cancer serum using 2-D differential gel electrophoresis/MALDI-TOF/TOF and data validation by routine clinical assays. Electrophoresis 2006, 27, 1641-1650.
61. Skates, S. J.; Horick, N. K.; Moy, J. M.; Minihan, A. M.; Seiden, M. V.; Marks, J. R.; Sluss, P.; Cramer, D. W. Pooling of case specimens to create standard serum sets for screening cancer biomarkers. Cancer Epidemiol., Biomarkers Prev. 2007, 16, 334-341.
62. Petersen, S. V.; Valnickova, Z.; Enghild, J. J. Pigment-epithelium- derived factor (PEDF) occurs at a physiologically relevant concentration in human blood: purification and characterization. Biochem. J. 2003, 374, 199-206.
63. Hegmans, J. P.; Bard, M. P.; Hemmes, A.; Luider, T. M.; Kleijmeer, M. J.; Prins, J. B.; Zitvogel, L.; Burgers, S. A.; Hoogsteden, H. C.; Lambrecht, B. N. Proteomic analysis of exosomes secreted by human mesothelioma cells. Am. J. Pathol. 2004, 164, 1807-1815.
64. Mears, R.; Craven, R. A.; Hanrahan, S.; Totty, N.; Upton, C.; Young, S. L.; Patel, P.; Selby, P. J.; Banks, R. E. Proteomic analysis of melanoma-derived exosomes by two-dimensional polyacrylamide gel electrophoresis and mass spectrometry. Proteomics 2004, 4, 4019-4031.
65. All-Ericsson, C.; Girnita, L.; Seregard, S.; Bartolazzi, A.; Jager, M. J.; Larsson, O. Insulin-like growth factor-1 receptor in uveal melanoma: a predictor for metastatic disease and a potential therapeutic target. Invest. Ophthalmol. Vis. Sci. 2002, 43, 1-8.
66. Royds, J. A.; Rennie, I. G.; Parsons, M. A.; Timperley, W. R.; Taylor, C. B. Enolase isoenzymes in uveal melanomas - a possible parameter of malignancy. Br. J. Ophthalmol. 1983, 67, 244-248.
67. Bajcsy, P.; Lee, S. C.; Lin, A.; Folberg, R. Three-dimensional volume reconstruction of extracellular matrix proteins in uveal melanoma from fluorescent confocal laser scanning microscope images. J. Microsc. 2006, 221, 30-45.
68. Luyten, G. P.; van der Spek, C. W.; Brand, I.; Sintnicolaas, K.; de Waard-Siebinga, I.; Jager, M. J.; de Jong, P. T.; Schrier, P. I.; Luider, T. M. Expression of MAGE, gp100 and tyrosinase genes in uveal melanoma cell lines. Melanoma Res. 1998, 8, 11-6.
69. Ma, D.; Luyten, G. P.; Luider, T. M.; Jager, M. J.; Niederkorn, J. Y. Association between NM23-H1 gene expression and metastasis of human uveal melanoma in an animal model. Invest. Ophthalmol. Vis. Sci. 1996, 37, 2293-2301.